Back
Citius Oncology Vs. Theriva Biologics Industry Stock Comparison
Buy
62
CTOR
Citius Oncology
Last Price:
1.57
Seasonality Move:
--
Buy
74
TOVX
Theriva Biologics
Last Price:
3.89
Seasonality Move:
-14.26%
Buy
62
Citius Oncology (CTOR)
is a Buy
Is Citius Oncology a Buy, Sell or Hold?
- The current Citius Oncology [CTOR] share price is $1.56. The Score for CTOR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- CTOR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
74
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $3.80. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CTOR Stock Price Chart
What is Citius Oncology's stock price today?
-
The Citius Oncology share price today is $1.56
The current trend is relatively stagnant and CTOR is experiencing slight selling pressure.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $3.80
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight selling pressure.
CTOR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 25.59 | Sell |
| Chaikin Money Flow: | -191678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 45.75 | Sell |
| Chaikin Money Flow: | -12459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 4.72) | Buy |
| Bollinger Bands (100): | (-0.5 - 2.42) | Buy |
CTOR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.63 | Sell |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 1.56 | Sell |
| 20-day EMA: | 1.21 | Buy |
| 50-day EMA: | 0.68 | Buy |
| 200-day EMA: | 0.2 | Buy |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.88 | Sell |
| 20-day SMA: | 3.73 | Buy |
| 50-day SMA: | 1.63 | Buy |
| 200-day SMA: | 0.72 | Buy |
| 8-day EMA: | 3.86 | Sell |
| 20-day EMA: | 3.36 | Buy |
| 50-day EMA: | 2.2 | Buy |
| 200-day EMA: | 1 | Buy |
Citius Oncology Earnings Growth & CTOR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Citius Oncology Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||